135 related articles for article (PubMed ID: 36329881)
1. Decreased IGF-1 level is associated with restrained amino acid metabolism in NSCLC with diabetes mellitus.
Lv H; Zhang F; Liang C; Liu X; Ma Y; Li J; Ye Y; Si S; Liu Y; Heng H; Geng H
Front Endocrinol (Lausanne); 2022; 13():1031798. PubMed ID: 36329881
[TBL] [Abstract][Full Text] [Related]
2. Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians.
Wang Z; Tang J; Jin E; Zhong Y; Zhang L; Han X; Liu J; Cheng Y; Hou J; Shi X; Qi H; Qian T; Yuan L; Hou X; Yin H; Liang J; Zhao M; Huang L; Qu J
Front Mol Biosci; 2022; 9():871291. PubMed ID: 35755823
[No Abstract] [Full Text] [Related]
3. Small intestine proteomics coupled with serum metabolomics reveal disruption of amino acid metabolism in Chinese hamsters with type 2 diabetes mellitus.
Wang C; Yu J; Zhang R; Wang W; Shi Z; Liu Y; Song G; Wang H; Han N; Huang L; An Y; Tian S; Chen Z
J Proteomics; 2020 Jul; 223():103823. PubMed ID: 32428569
[TBL] [Abstract][Full Text] [Related]
4. Expression characteristics of proteins of the insulin-like growth factor axis in non-small cell lung cancer patients with preexisting type 2 diabetes mellitus.
Ding J; Tang J; Chen X; Men HT; Luo WX; Du Y; Ge J; Li C; Chen Y; Cheng K; Qiu M; Liu JY
Asian Pac J Cancer Prev; 2013; 14(10):5675-80. PubMed ID: 24289561
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Fingerprints of Circulating IGF-1 and the IGF-1/IGFBP-3 Ratio: A Multifluid Metabolomics Study.
Knacke H; Pietzner M; Do KT; Römisch-Margl W; Kastenmüller G; Völker U; Völzke H; Krumsiek J; Artati A; Wallaschofski H; Nauck M; Suhre K; Adamski J; Friedrich N
J Clin Endocrinol Metab; 2016 Dec; 101(12):4730-4742. PubMed ID: 27710242
[TBL] [Abstract][Full Text] [Related]
6. Metabolic network-based identification of plasma markers for non-small cell lung cancer.
Guo L; Li L; Xu Z; Meng F; Guo H; Liu P; Liu P; Tian Y; Xu F; Zhang Z; Zhang S; Huang Y
Anal Bioanal Chem; 2021 Dec; 413(30):7421-7430. PubMed ID: 34617154
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the fecal microbiota and serum metabolome in unstable angina pectoris patients.
Liu L; Luo F
Front Biosci (Landmark Ed); 2022 Mar; 27(3):100. PubMed ID: 35345332
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of IGF-I and IGFBP-3 in patients with lung cancer during chemotherapy.
Izycki T; Chyczewska E; Naumnik W; Ossolinska M
Oncol Res; 2006; 16(1):49-54. PubMed ID: 16783968
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive analysis of metabolomics and transcriptomics in non-small cell lung cancer.
Ruiying C; Zeyun L; Yongliang Y; Zijia Z; Ji Z; Xin T; Xiaojian Z
PLoS One; 2020; 15(5):e0232272. PubMed ID: 32374740
[TBL] [Abstract][Full Text] [Related]
10. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of serum amino acid profiles' utility in non-small cell lung cancer detection in Polish population.
Klupczynska A; Dereziński P; Dyszkiewicz W; Pawlak K; Kasprzyk M; Kokot ZJ
Lung Cancer; 2016 Oct; 100():71-76. PubMed ID: 27597283
[TBL] [Abstract][Full Text] [Related]
12. Large-Scale Longitudinal Metabolomics Study Reveals Different Trimester-Specific Alterations of Metabolites in Relation to Gestational Diabetes Mellitus.
Zhao H; Li H; Chung ACK; Xiang L; Li X; Zheng Y; Luan H; Zhu L; Liu W; Peng Y; Zhao Y; Xu S; Li Y; Cai Z
J Proteome Res; 2019 Jan; 18(1):292-300. PubMed ID: 30488697
[TBL] [Abstract][Full Text] [Related]
13. Significant metabolic alterations in non-small cell lung cancer patients by epidermal growth factor receptor-targeted therapy and PD-1/PD-L1 immunotherapy.
Yan C; Wu D; Gan L; Wang J; Yang W; Xu B
Front Pharmacol; 2022; 13():949745. PubMed ID: 36034789
[No Abstract] [Full Text] [Related]
14. Arabinoxylan Attenuates Type 2 Diabetes by Improvement of Carbohydrate, Lipid, and Amino Acid Metabolism.
Nie Q; Chen H; Hu J; Gao H; Fan L; Long Z; Nie S
Mol Nutr Food Res; 2018 Oct; 62(20):e1800222. PubMed ID: 30211972
[TBL] [Abstract][Full Text] [Related]
15. Untargeted serum metabolomics reveals Fu-Zhu-Jiang-Tang tablet and its optimal combination improve an impaired glucose and lipid metabolism in type II diabetic rats.
Tao Y; Chen X; Cai H; Li W; Cai B; Chai C; Di L; Shi L; Hu L
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():222-232. PubMed ID: 27866845
[TBL] [Abstract][Full Text] [Related]
16. Association of preoperative serum IGF- I concentration with clinicopathological parameters in patients with non-small cell lung cancer.
Fu SL; Tang HX; Liao YD; Jiang WY; Xu QZ; Deng Y; Fu XN
J Huazhong Univ Sci Technolog Med Sci; 2013 Apr; 33(2):224-227. PubMed ID: 23592134
[TBL] [Abstract][Full Text] [Related]
17. UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats.
Wang H; Teng Y; Li S; Li Y; Li H; Jiao L; Wu W
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771066
[No Abstract] [Full Text] [Related]
18. Assessment of plasma amino acids, purines, tricarboxylic acid cycle metabolites, and lipids levels in NSCLC patients based on LC-MS/MS quantification.
Cang S; Liu R; Mu K; Tang Q; Cui H; Bi K; Zhang Y; Li Q
J Pharm Biomed Anal; 2022 Nov; 221():114990. PubMed ID: 36208488
[TBL] [Abstract][Full Text] [Related]
19. Untargeted serum metabolomics and tryptophan metabolism profiling in type 2 diabetic patients with diabetic glomerulopathy.
Zhang F; Guo R; Cui W; Wang L; Xiao J; Shang J; Zhao Z
Ren Fail; 2021 Dec; 43(1):980-992. PubMed ID: 34157945
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes.
Wang Z; Tang J; Jin E; Ren C; Li S; Zhang L; Zhong Y; Cao Y; Wang J; Zhou W; Zhao M; Huang L; Qu J
Front Endocrinol (Lausanne); 2022; 13():986303. PubMed ID: 36157454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
